© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury
aCentre for Cardiovascular Science, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK
bMRC Centre for Inflammation Research, University of Edinburgh, Edinburgh EH8 9AG, UK
* Corresponding author. Tel.: +44-131-651-1193; fax: +44-131-650-6527. ian.megson{at}ed.ac.uk
Objective: Platelet adhesion to areas of endothelial denudation following angioplasty is an important factor contributing to the limitations of this technique. Lipophilic S-nitrosothiols like S-nitroso-N-valerylpenicillamine (SNVP) are novel nitric oxide (NO) donor drugs with anti-platelet and vasodilator properties that are selective for areas of endothelial denudation. Here we assess the inhibitory effect of SNVP on platelet adhesion to angioplastied rabbit carotid arteries. Methods: A rabbit model was used to measure adhesion of radiolabelled platelets to carotid arteries following balloon angioplasty. The effects of SNVP were compared to the conventional NO donor, nitroglycerin (NTG). Electron microscopy was used to visualize adhering platelets. Results: Angioplasty resulted in endothelial denudation with only a modest reduction in vessel contractility. In vivo administration of NTG and SNVP (both 200 nmol) prevented the hyper-aggregability (
20%) of circulating platelets caused by angioplasty. However, bolus NTG failed to inhibit adhesion of radiolabelled platelets 30 min after angioplasty, despite inducing a transient 30% reduction in systemic blood pressure. In contrast, equimolar SNVP had little effect on blood pressure but markedly inhibited platelet adhesion (62% compared to control; P=0.003). Platelet adhesion was confirmed with electron microscopy. Conclusion: The prolonged effects of SNVP at sites of endothelial damage suggest that novel S-nitrosothiols might offer a means of targeted delivery of an antiplatelet agent to areas of vascular injury.
KEYWORDS ACh, acetylcholine; ADP, adenosine 5'-diphosphate; Hep-Sal, heparinised saline; L-NAME, N
-nitro-L-arginine methyl ester; NO, nitric oxide; NTG, nitroglycerin; PE, phenylephrine; PRP, platelet rich plasma; SNVP, S-nitroso-N-valerylpenicillamine
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Marcondes, M. H. M. Cardoso, R. P. Morganti, S. M. Thomazzi, S. Lilla, F. Murad, G. De Nucci, and E. Antunes Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: A role for {alpha}-actinin nitration PNAS, February 28, 2006; 103(9): 3434 - 3439. [Abstract] [Full Text] [PDF] |
||||
